manilatimes1 天
Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Activity
(Nasdaq: IKT) ("Inhibikase” or "Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor ...